1. Join LLS Partner, Triage Cancer, for the 2021 Webinar Series

    LLS partner, Triage Cancer, is holding its 2021 webinar series now. Triage Cancer offers free educational webinars on practical and legal cancer survivorship issues that impact people beyond diagnosis. Our free webinars discuss various issues related to navigating finances after a cancer diagnosis, health insurance, disability insurance, work and employment rights, advocacy, estate planning, clinical trials, and more. All webinars are open to the general public, including individuals d...

    Read More
  2. Federally Facilitated ACA Plan Enrollment Now Open!

    Cancer patients have faced unique challenges in access to care, particularly during the COVID-19 pandemic. Cancer care can make these challenges more difficult to manage, especially for uninsured patients and their caregivers. The Federal government has recognized the need to provide insurance opportunities by mandating a special enrollment period for Federally run Affordable Care Act (ACA) plans from February 15, 2021 through May 15, 2021. Although this is not applicable to state run ...

    Read More
  3. February 2021-Patient Education Programs

    Emerging Therapies in Blood Cancer Treatment A Virtual Education Program (Ohio River Valley) February 4, 2021 6:30pm – 8:00pm (ET) https://www.lls.org/events/emerging-therapies-in-blood-cancer-treatment-ORV Northern California Blood Cancer Conference 2021 A Virtual Education Conference (Northern California) February 6, 2021 9:30am - 1:30pm (PT) https://na.eventscloud.com/website/19077/ Meet the Doctors: A Post ASH Symposium A Virtual Education Conference (Lower Plains) Febr...

    Read More
  4. FDA Approval: Treatment Advance for Patients with Rare Blood Cell Disorder

    Rye Brook, N.Y. (January 19, 2021) – On January 15, the U.S. Food and Drug Administration (FDA) announced approval of daratumumab plus hyaluronidase (Darzalex Faspro®) for adults with newly diagnosed light chain (AL) amyloidosis, a rare and serious blood cell disorder that may occur by itself or with myeloma. Daratumumab is used in combination with chemotherapy agents bortezomib (Velcade®) and cyclophosphamide (Cytoxan® or Neosar®), plus the corticosteroid dexamethasone in these patient...

    Read More
  5. LLS CELEBRATES NEW DRUG APPROVAL FOR A RARE FORM OF CHILDHOOD CANCER

    At The Leukemia & Lymphoma Society (LLS), we celebrate every advancement toward our mission of curing blood cancer and improving the quality of life for patients and their families. Today’s reason to celebrate is the news that the U.S. Food and Drug Administration (FDA) has approved a new treatment for children with a rare type of cancer called ALK-positive anaplastic large cell lymphoma (ALCL). ALCL constitutes approximately 10-15% of non-Hodgkin lymphoma in the pediatric population...

    Read More
  6. Practicing Self-Advocacy During My PTCL Journey

    In partnership with The LLS Blog invites Aaron, who was diagnosed with peripheral T-cell lymphoma (PTCL), to share his reflections on becoming a self-advocate throughout his cancer experience. Read his powerful first-hand account below.

    Read More
  7. Research Highlight: Changing the Landscape of Treatment for Multiple Myeloma (Part 1)

    Multiple myeloma (MM) made up close to 20% of all new blood cancer cases diagnosed in the US in 2019. This disease is characterized by the uncontrolled proliferation of abnormal monoclonal plasma cells in the bone marrow. As these abnormal cells grow in excess, they disrupt normal cell production, which can result in a range of complications, particularly in the bones, blood, kidney and immune system. People with multiple myeloma develop tumors in more than one location inside and sometimes o...

    Read More
  8. Celebrating Survivorship: Lyndi Abote

    In March 2019 I began feeling off but I didn't know what it was. I thought perhaps it was a loss of relationship that broke me to my core or that fact that an old friend had asked me to be kidney donor for someone I had never known. I agreed to be tested to see if I was a possible match and I was. In October, it was discovered that a possible blood clot had formed from all of this. I was having continual pain in my right shoulder blade. After a series of trigger point infections, a last ditch...

    Read More
  9. Celebrate the Holidays Safely

    We could all use a little holiday cheer this year. According to the Centers for Disease Control and Prevention (CDC), the safest way to celebrate the winter holidays is to celebrate at home with people who live with you. Blood cancer patients and survivors are not at greater risk of catching COVID-19, but a blood cancer diagnosis might put you at a greater risk of getting sicker if you do get the virus. While it is safest to gather only with those in your home, if you do plan to host or atten...

    Read More
  10. January 2021- Patient Education Programs

    Women's Health after a Blood Cancer Diagnosis: Unique Concerns and What's Next A Virtual Education Program (NJ Region) January 11, 2021 6:00pm – 8:00pm (ET) https://www.lls.org/events/women%27s-health-after-a-blood-cancer-diagnosis Targeted Therapies in Non-Hodgkin Lymphoma A Virtual Education Program (Connecticut-Hudson Valley Region) January 12, 2021 6:00pm – 7:30pm (ET) https://www.lls.org/events/targeted-therapies-in-non-hodgkin-lymphoma Meet the E...

    Read More